While we've done the DD and know the potential catalysts - a lot of people (mostly traders) either don't know the potential catalysts or don't think they will pan out. I'm in a trading chatroom that usually has approximately 500 active traders on any given day. CYDY is looked at as an OTC pump in that chatroom, and Redchip is looked at as a notorious OTC pump promoter. I obviously think these people will be proven wrong in the (hopefully) not-so-long run or I wouldn't have almost my entire account invested here - but that's how the majority of traders look at CytoDyn.

Just some perspective on why the short interest is so high. The good new is approximately 90%-95% of traders lose money, lol.